{
  "id": "92fb683394a7cd6b",
  "title": "Global Study Marks Major Treatment Advance for Tough - to - Treat High - Risk Blood Cancer",
  "description": "20260210T054500Z",
  "content": "",
  "source": "newswise.com",
  "source_url": "https://www.newswise.com/articles/global-study-marks-major-treatment-advance-for-tough-to-treat-high-risk-blood-cancer",
  "published_at": "20260210T054500Z",
  "fetched_at": "2026-02-11T00:34:18.892628+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": "United States",
  "raw_data": {
    "url": "https://www.newswise.com/articles/global-study-marks-major-treatment-advance-for-tough-to-treat-high-risk-blood-cancer",
    "url_mobile": "",
    "title": "Global Study Marks Major Treatment Advance for Tough - to - Treat High - Risk Blood Cancer",
    "seendate": "20260210T054500Z",
    "socialimage": "",
    "domain": "newswise.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}